Dinoksilin je sintetičko jedinjenje koje je razvijeno za primenu u naučnim istraživanjima. Dinoksilin deluje kao potentan pun agonist na svih pet podtipova dopaminskog receptora.[1][2][3]
^Grubbs RA, Lewis MM, Owens-Vance C, Gay EA, Jassen AK, Mailman RB, Nichols DE (2004). „8,9-dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (dinoxyline), a high affinity and potent agonist at all dopamine receptor isoforms”. Bioorganic & Medicinal Chemistry. 12 (6): 1403—12. PMID15018913. doi:10.1016/j.bmc.2004.01.008.
^Ryman-Rasmussen JP, Nichols DE, Mailman RB (2005). „Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists”. Molecular Pharmacology. 68 (4): 1039—48. PMID15985612. doi:10.1124/mol.105.012153.
^Zhang J, Xiong B, Zhen X, Zhang A (2009). „Dopamine D1 receptor ligands: where are we now and where are we going”. Medicinal Research Reviews. 29 (2): 272—94. PMID18642350. doi:10.1002/med.20130.
